The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
Combination of bendamustine with rituximab treatment may be an effective regimen for immune-mediated neuropathies associated with hematologic malignancy.
An open-source smartphone and web application has been developed to help predict clinical malignancy and survival outcomes for meningioma.
True acupuncture is more effective than placebo and standard care in reducing the number and severity of radiation-induced xerostomia (dry mouth) symptoms at 1 year following treatment in patients with head and neck cancer.
Researchers found the use of acupuncture and/or acupressure is associated with reduced cancer pain and decreased use of analgesics.
Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.
A stepped care approach seems beneficial for insomnia treatment among cancer survivors.
A study finds that in characterization of peripheral nerve sheath tumors as benign or malignant in patients with neurofibromatosis type 1, MRI-obtained apparent diffusion coefficient and FDG-PET/CT-obtained maximum standardized uptake values are excellent imaging markers.
The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
A comparison of AEDs finds that while most were not associated with skin cancer, carbamazepine and lamotrigine were associated with squamous cell carcinoma.
